IRADIMED CORPORATION Announces Second Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
01 août 2024 09h29 HE
|
iRadimed Corporation
Reports record revenue of $17.9 million for the second quarter of 2024, an increase of 11.2 percent over the comparable period 2023.Reports GAAP diluted EPS of $0.38 and non-GAAP diluted EPS of $0.42...
IRADIMED CORPORATION to Hold 2024 Second Quarter Financial Results Conference Call on August 1st
25 juil. 2024 08h30 HE
|
iRadimed Corporation
Winter Springs, Fla., July 25, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 second quarter financial results before the market...
IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global Market
07 juin 2024 08h30 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., June 07, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (“Iradimed”) (NASDAQ: IRMD), a leading provider of innovative magnetic resonance imaging (MRI) compatible medical...
IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
02 mai 2024 08h30 HE
|
iRadimed Corporation
Reports record revenue of $17.6 million for the first quarter of 2024.Reports GAAP diluted EPS of $0.32 and non-GAAP diluted EPS of $0.36 for the first quarter of 2024.Reports first quarter of 2024...
IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd
25 avr. 2024 16h05 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 first quarter financial results before the market...
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
13 mars 2024 16h30 HE
|
iRadimed Corporation
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
08 févr. 2024 08h05 HE
|
iRadimed Corporation
Reports record revenue of $17.5 million for the fourth quarter and $65.6 million for the full year of 2023. Reports GAAP diluted EPS of $0.36 and non-GAAP diluted EPS of $0.39 for the fourth quarter...
IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.
01 févr. 2024 16h05 HE
|
iRadimed Corporation
WINTER SPRINGS, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 fourth quarter financial results before the market...
IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue
09 janv. 2024 08h30 HE
|
iRadimed Corporation
Reports preliminary fourth quarter 2023 revenue of $17.5 million WINTER SPRINGS, Fla., Jan. 09, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in developing...
IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference
02 janv. 2024 16h30 HE
|
iRadimed Corporation
IRADIMED CORPORATION Announces Participation in 42nd Annual J.P. Morgan Healthcare Conference